Showing posts with label
biologics
.
Show all posts
Showing posts with label
biologics
.
Show all posts
Monday, January 12, 2026
Why we own BEAM Therapeutics - update January 2026
›
Beam Therapeutics (NASDAQ: BEAM) Updated Investment & Business Report – January 2026 Theme: Precision genetic medicine through base...
Monday, June 17, 2024
Xencor is a cutting edge tech company in biologics and monoclonal antibodies!
›
Xencor is indeed a viable technology company, particularly in the biotechnology and pharmaceutical sectors. The company is known for its ad...
›
Home
View web version
